Inhaled Carbon Monoxide

DRUG4 trials

Sponsors

Mallinckrodt, Queen's University, Brigham and Women's Hospital, CAN WANG

Conditions

Idiopathic Pulmonary FibrosisIleusKidney TransplantationMiscellaneous Disorders in the Fetus or Newborn

Phase 2

Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients

WithdrawnNCT00531856

MallinckrodtKidney Transplantation

Start: 2007-08-31End: 2011-08-31Updated: 2016-10-19

Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients

WithdrawnNCT00531856

MallinckrodtKidney Transplantation

Start: 2007-08-31End: 2011-08-31Updated: 2016-10-19

Study of Inhaling Carbon Monoxide to Treat Patients With Intestinal Paralysis After Colon Surgery.

TerminatedNCT01050712

Queen's UniversityIleus

Start: 2011-04-30End: 2013-09-30Updated: 2015-11-17

Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis

CompletedNCT01214187

Brigham and Women's HospitalIdiopathic Pulmonary Fibrosis

Start: 2011-07-31End: 2015-04-30Updated: 2017-06-14

Unknown Phase

The Safety and Adverse Reaction Study of Neonatal to Inhaled Carbon Monoxide

CAN WANGMiscellaneous Disorders in the Fetus or Newborn

Start: 2012-04-30End: 2013-12-31Target: 24Updated: 2013-03-28

Related Papers

An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis

ERJ Open Research2024-01-013 citations

A Phase II Clinical Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis.

2017-10-3168 citations